Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Digital Therapeutics | Neuroglee DTx
Neuroglee Therapeutics discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2025 – November 2026 · 2 captures · latest observed messagingNeuroglee Health
Empowering people living with neurological conditions and their families to lead productive, meaningful lives by revolutionizing personalized health care and the patient experience.
6 November 2026 · Neuroglee Healthcurrent websiteHistorical capture not publicly available
Seen January 2025 · 1 captureCognitive Care Reimagined
Empowering people living with neurological conditions and their families to lead productive, meaningful lives by revolutionizing personalized health care and the patient experience.
Empowering people living with neurological conditions and their families to lead productive, meaningful lives by revolutionizing personalized health care and the patient experience.
January 2021 – February 2024 · 4 capturesReimagining Cognitive Care
Empowering people living with neurological conditions and their families to lead productive, meaningful lives by revolutionizing personalized health care and the patient experience.
Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.
Neuroglee announces pre-seed and Series A funding
Neuroglee Therapeutics announced a pre-seed round and a later Series A to advance its digital therapeutics and virtual-care platform for neurodegenerative diseases. The company also updated its positioning and added a careers page in the same early period.
Between November 2020 and January 2021, Neuroglee Therapeutics announced on its homepage that it raised $2.3M in pre-seed funding to advance digital therapeutics for neurodegenerative diseases. [1]
Between November 2020 and January 2021, the homepage headline changed from “Digital Therapeutics | Neuroglee DTx” to “Neuroglee: Reimagining Care for Neurodegenerative Diseases”. [2]
Between November 2020 and January 2021, Neuroglee Therapeutics added a careers page. [3]
Between July 2021 and September 2023, Neuroglee Therapeutics announced on its homepage that its “AI in Healthcare Virtual-Care Platform” raised $10 Million Series A. [4]
Cite this record
StartupHistory, “Neuroglee Therapeutics” company record, https://startuphistory.org/c/neuroglee.com